AbbVie Inc. NYQ · ABBV

IHE vs IXJ: Which Popular Healthcare ETF Is the Better Buy for Investors?

The Motley Fool · 2h ago

Clinical Stage Partnering Terms and Agreements in Pharmaceuticals and Biotechnology 2020-2026 | Benchmark More Than 1,800 Biopharma Deals with Various Indexes

GlobeNewswire Inc. · 1d ago

Healthcare Investing in 2026: iShares Global Healthcare ETF Outperforms Invesco Health Care ETF

The Motley Fool · 2d ago

Autoimmune Disease Therapeutics Market Size to Reach USD 137.85 Billion by 2035 as Biologics and Precision Medicine Drive Growth | SNS Insider

GlobeNewswire Inc. · 3d ago

Nxera Pharma Webinar for Financial Results Presentation - 2Q2026

GlobeNewswire Inc. · 3d ago

Which High-Yield ETF Is a Better Buy in 2026: Vanguard VYM vs iShares HDV?

The Motley Fool · 4d ago

VCSH vs ISTB: Which Short-Duration Bond ETF Is the Best Investment in 2026?

The Motley Fool · 5d ago

AbbVie Is Already a Dividend King. Here's Why the $10.9 Billion Apogee Deal Could Make It a Dynasty

The Motley Fool · 7d ago

Vanguard Health Care vs. VanEck Pharmaceutical: How Do These ETFs Stack Up?

The Motley Fool · 9d ago

ProShares vs. iShares: Is NOBL or HDV the Better Dividend ETF for Investors?

The Motley Fool · 9d ago

Internationales Beratergremium für Handel und Investitionen in Shandong 2026 tagt in Jinan

GlobeNewswire Inc. · 9d ago

Invesco Pharmaceuticals ETF or First Trust Biotech Fund: Which Drug Maker-Focused Fund Should You Buy in 2026?

The Motley Fool · 10d ago

Abbott Labs vs. Glaukos: Which Healthcare Stock Is a Better Buy in 2026?

The Motley Fool · 10d ago

ASDS Opens Registration for Annual Conference in San Diego

GlobeNewswire Inc. · 10d ago

The Dividend ETF Quietly Outperforming the S&P 500

The Motley Fool · 11d ago

Genmab Announces TEPKINLY® (epcoritamab) in Combination with Lenalidomide and Rituximab is Approved by the European Commission for the Treatment of Relapsed or Refractory Follicular Lymphoma

GlobeNewswire Inc. · 12d ago

Fidelity Health Care vs. State Street Biotech: Which ETF Fits Your Portfolio Best?

The Motley Fool · 13d ago

Which Is the Better High Dividend ETF, iShares' HDV or Fidelity's FDVV?

The Motley Fool · 14d ago

Exploring SKYRIZI's Exceptional Growth: Revenue and Market Expansion Analysis

GlobeNewswire Inc. · 15d ago

Big Pharma Has a Case of Merger Mania

The Motley Fool · 18d ago

AbbVie Stock Hits a New 52-Week High. Has It Gotten Too Expensive to Buy?

The Motley Fool · 19d ago

New study examines real-world switching patterns after patients transition from Humira to biosimilars

GlobeNewswire Inc. · 19d ago

Fidelity (FHLC) vs. iShares (IXJ): Which Healthcare ETF Delivers Better Value?

The Motley Fool · 22d ago

Here's How Much You'd Need to Invest in HDV to Generate $500 per Month in Dividends

The Motley Fool · 25d ago

3 Monster Stocks to Hold for the Next 10 Years

The Motley Fool · 25d ago